For the quarter ending 2026-03-31, PMVP has $96,562K in assets. $8,595K in debts. $39,130K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 39,130 | 36,337 | 44,127 | |
| Marketable securities, current | 54,419 | 92,913 | 98,147 | |
| Prepaid expenses and other current assets | 2,231 | 3,199 | 3,037 | |
| Total current assets | 95,780 | 132,449 | 145,311 | |
| Total property and equipment | 1,563 | 1,549 | - | |
| Less accumulated depreciation | 1,360 | 1,294 | - | |
| Property and equipment, net | 203 | 255 | 287 | |
| Right-of-use assets | 283 | 891 | 977 | |
| Marketable securities, noncurrent | - | - | 6,032 | |
| Other assets | 296 | 249 | 248 | |
| Total assets | 96,562 | 133,844 | 152,855 | |
| Accounts payable | 1,631 | 3,399 | 2,598 | |
| Accrued expenses | 6,671 | 8,515 | 8,632 | |
| Operating lease liabilities, current | 293 | 390 | 377 | |
| Total current liabilities | 8,595 | 12,304 | 11,607 | |
| Operating lease liabilities, noncurrent | 0 | 541 | 643 | |
| Total liabilities | 8,595 | 12,845 | 12,250 | |
| Additional paid-in capital | 552,474 | 549,325 | 547,942 | |
| Accumulated deficit | -464,492 | -428,417 | -407,358 | |
| Accumulated other comprehensive income | -15 | 91 | 21 | |
| Total stockholders equity | 87,967 | 120,999 | 140,605 | |
| Total liabilities and stockholders equity | 96,562 | 133,844 | 152,855 | |
PMV Pharmaceuticals, Inc. (PMVP)
PMV Pharmaceuticals, Inc. (PMVP)